MARCH · Health & Regulated
Compliance-first · GACP · GMP · GDP
Compliance consulting and import for the medical-cannabis industry. We qualify companies to GACP, GMP and GDP, build their SOP and quality systems, train their teams, and structure compliant import and export of medicines, flower and APIs — in Brazil and abroad.
For producers, laboratories, importers and distributors in Brazil and abroad: we qualify your operation to pharmaceutical standards, build the quality system behind it, train your people and clear the way across borders.
We prepare and qualify cultivation, laboratory and distribution operations to Good Agricultural & Collection, Manufacturing and Distribution Practices — ready for audit and certification.
The full SOP and quality-management system for pharma cannabis — procedures, batch records, deviations, CAPA and change control, built to pass inspection.
Hands-on advisory on cultivation, lab set-up, genetics and product development — from first crop to a reproducible pharmaceutical product.
We train your teams on GACP/GMP/GDP, documentation, controlled-substance handling and inspection readiness — so compliance holds after we leave.
Compliant import and export of finished medicines, medical-cannabis flower and APIs — dossiers, certificates, controlled-substance permits and customs documentation.
The regulatory pathway, the licensed holder and the registration — ANVISA in Brazil, EU-GMP in Europe — so your product reaches the market the right way.
We represent licensed producers and bring compliant products to Brazil through the only channel that lasts — the regulated one.
Import of finished medical cannabis and CBD products under ANVISA authorization, via a licensed Brazilian holder/importer.
Product dossiers, ANVISA registration by category, Portuguese labelling and controlled-substance handling — compliance-first.
Commercial representation under Brazilian law 4.886/1965, placing products with distributors, pharmacies and specialised channels.
Import and product authorization through a licensed holder; nothing enters outside the regulated channel.
Products reach patients only via medical prescription, within Brazil's regulated framework.
Portuguese labels to Brazilian standards; certificates, analyses and import papers in order.
Full chain-of-custody and reporting for a controlled category, from origin to dispensing.
Europe, Brazil, Argentina, Colombia, Canada and Australia — we know the licensing, the origin rules and the access models on both ends of the chain, and build the compliant route between them.
EU-GMP licensed pharmaceutical import and distribution — the quality bar the whole chain is measured against.
ANVISA import authorization, product registration and commercial representation — our destination market.
State-backed medical-cannabis production and Mercosur origin (0% tariff) — a competitive supply base.
One of the world's largest licensed cultivation and extract bases, and a fast-growing export origin.
A mature licensed-producer framework with GMP flower and extract built for export.
An established medical-cannabis market and prescriber model — a benchmark for patient access.
Tell us where you are — a crop, a lab, a product, a shipment. We'll map the path to GACP, GMP, GDP or ANVISA, and tell you honestly what it takes.
Book a 30-minute consultationmarina.abreu@marchinternacional.com.br · marchinternacional.com.br · WhatsApp